LoRa Alliance® Announces New LoRaWAN® Payload Codec API Feature that Accelerates Device Onboarding to Enable Massive IoT
Release of a standards-based Payload Codec API simplifies ease of deployment to drive scale LoRaWAN®…
Release of a standards-based Payload Codec API simplifies ease of deployment to drive scale LoRaWAN®…
Toronto, Ontario–(Newsfile Corp. – October 25, 2022) – MIRL will be listed on the cryptocurrency…
Seattle, Washington–(Newsfile Corp. – October 25, 2022) – Rumors and reports have been circulating online…
Singapore, Oct 25, 2022 – (ACN Newswire) – On 9 and 10 November 2022, education…
KUCHING, MALAYSIA, Oct 25, 2022 – (ACN Newswire) – Civil engineering specialist Sarawak Consolidated Industries…
Malang, East Java, Indonesia, Oct 25, 2022 – (ACN Newswire) – The National Food Agency…
BOSTON–(BUSINESS WIRE)–BackBay Communications, a leading public relations and integrated marketing firm focused on the financial…
Oosto’s Vision AI platform optimizes its neural networks for smart cameras, near-edge devices and access…
ST. IGNATIUS, Mont.–(BUSINESS WIRE)–S&K Aerospace, LLC (SKA) has been awarded a prime contract by the…
PAM provider joins a select group at CVE® Program, which identifies, assigns and publishes cybersecurity…
Eighty-three percent of MercuryGate user reviews (out of 28 overall reviews) as of June 2022…
Report showcases industry benchmark data to unleash financial digital transformation and innovation for global brands…
Company’s AI-Powered Risk Decisioning Platform recognized in the “Best Smart Banking Tech Solution – AI-Driven…
Company provides plans to accelerate its growth of specialties businesses TEL AVIV, Israel–(BUSINESS WIRE)–ICL (NYSE:…
New Blancco ESG report reveals the company’s continued circular economy focus, its positive social impact…
Fifth phase II trial assessing the impact of UV1 in various immunotherapy combinations Enrollment of…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – October 25, 2022 Idorsia…
NFL Biosciences: 2022 first-half business and earnings Phase II/III clinical trial for the drug candidate…
REGULATED INFORMATION New company’s pipeline enriched with serious inflammatory indications in addition to its original…
Ad hoc announcement pursuant to Art. 53 LR Q3 sales grew +4% cc1 (-4% USD)…